title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,MRTX,0.005467,Somewhat-Bearish,-0.20525
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,MRTX,0.00644,Somewhat-Bearish,-0.232892
79 Biggest Movers From Yesterday,20220608T080800,https://www.benzinga.com/news/22/06/27602286/79-biggest-movers-from-yesterday,MRTX,0.060168,Neutral,0.011776
Stocks That Hit 52-Week Lows On Tuesday,20220426T174457,https://www.benzinga.com/markets/options/22/04/26818122/52-weeks-high-and-low-article,MRTX,0.00928,Neutral,0.007529
Stocks That Hit 52-Week Lows On Monday,20220425T160100,https://www.benzinga.com/markets/options/22/04/26791205/52-weeks-high-and-low-article,MRTX,0.008154,Neutral,0.004032
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,MRTX,0.013173,Neutral,-0.019011
Stocks That Hit 52-Week Lows On Wednesday,20220427T184104,https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article,MRTX,0.006956,Neutral,0.000817
Stocks That Hit 52-Week Lows On Thursday,20220421T175401,https://www.benzinga.com/markets/options/22/04/26742233/52-weeks-high-and-low-article,MRTX,0.021637,Neutral,0.018486
Stocks That Hit 52-Week Lows On Monday,20220314T161153,https://www.benzinga.com/news/22/03/26125409/stocks-that-hit-52-week-lows-on-monday,MRTX,0.003772,Neutral,-0.006788
"Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors",20231016T115000,https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-appoints-life-science-industry-leaders-jeremy-bender-teresa-bitetti-and-david-meek-to-its-board-of-directors-301957344.html,MRTX,0.044386,Neutral,-0.02047
"Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors",20231016T115000,https://www.newswire.ca/news-releases/fusion-pharmaceuticals-appoints-life-science-industry-leaders-jeremy-bender-teresa-bitetti-and-david-meek-to-its-board-of-directors-816998848.html,MRTX,0.044386,Neutral,-0.02047
"Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback",20231012T122400,https://www.zacks.com/stock/news/2164807/biotech-stock-roundup-bmy-grabs-mrtx-akro-down-on-study-data-alny-faces-setback,MRTX,0.101012,Neutral,0.064655
"Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs - bluebird bio  ( NASDAQ:BLUE ) , Amgen  ( NASDAQ:AMGN ) ",20230310T181042,https://www.benzinga.com/general/biotech/23/03/31300483/hefty-listing-price-of-new-drugs-for-cancer-rare-diseases-put-pressure-on-annual-hike-for-older-d,MRTX,0.210274,Somewhat-Bearish,-0.187033
"Snowflake, American Eagle, Digital Turbine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - American Eagle Outfitters  ( NYSE:AEO ) , Digital Turbine  ( NASDAQ:APPS ) ",20230525T103312,https://www.benzinga.com/news/23/05/32569285/snowflake-american-eagle-digital-turbine-and-other-big-stocks-moving-lower-in-thursdays-pre-market-s,MRTX,0.280615,Neutral,0.0
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,20231121T220100,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,MRTX,0.115121,Neutral,-0.033205
Mirati Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates,20230228T210100,https://www.prnewswire.com/news-releases/mirati-therapeutics-reports-fourth-quarter-and-full-year-2022-financial-results-and-recent-corporate-updates-301758465.html,MRTX,0.085782,Neutral,0.056144
McKesson  ( MCK )  Announces Availability of FDA-Accepted Drug,20221223T181500,https://www.zacks.com/stock/news/2032077/mckesson-mck-announces-availability-of-fda-accepted-drug,MRTX,0.068896,Neutral,-0.071218
Mirati's  ( MRTX )  Stock Rises on Q3 Earnings and Sales Beat,20221109T144700,https://www.zacks.com/stock/news/2016191/miratis-mrtx-stock-rises-on-q3-earnings-and-sales-beat,MRTX,0.20279,Somewhat-Bearish,-0.209564
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,MRTX,0.043539,Neutral,-0.058975
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,MRTX,0.041466,Neutral,0.011869
"EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday - Coupang  ( NYSE:CPNG ) , EnerSys  ( NYSE:ENS ) ",20231220T125009,https://www.benzinga.com/news/23/12/36322654/enersys-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday,MRTX,0.247838,Somewhat-Bullish,0.312475
3 Under-the-Radar Biotech Stocks to Buy in 2023,20230819T114000,https://www.fool.com/investing/2023/08/19/3-under-the-radar-biotech-stocks-to-buy-in-2023/,MRTX,0.097259,Neutral,0.033908
Stocks That Hit 52-Week Lows On Friday,20220527T192849,https://www.benzinga.com/markets/options/22/05/27444271/52-weeks-high-and-low-article,MRTX,0.077144,Neutral,0.001284
Stocks That Hit 52-Week Lows On Friday,20220422T162629,https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article,MRTX,0.012589,Neutral,0.000518
"Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday - AppLovin  ( NASDAQ:APP ) , Bed Bath & Beyond  ( NASDAQ:BBBY ) ",20221206T163102,https://www.benzinga.com/news/22/12/29978452/meta-platforms-herbalife-and-some-other-big-stocks-moving-lower-on-tuesday,MRTX,0.212115,Somewhat-Bearish,-0.276279
"Acrivon Therapeutics Announces the Appointment of Seasoned Biopharma Executive Charles Baum, M.D., Ph.D., a Recognized Leader in Clinical Precision Oncology, to its Board of Directors - Acrivon Therapeutics  ( NASDAQ:ACRV ) ",20230622T200000,https://www.benzinga.com/pressreleases/23/06/g32975171/acrivon-therapeutics-announces-the-appointment-of-seasoned-biopharma-executive-charles-baum-m-d-ph,MRTX,0.149038,Neutral,0.061614
Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022,20220811T200500,https://www.prnewswire.com/news-releases/poseida-therapeutics-provides-updates-and-financial-results-for-the-second-quarter-of-2022-301604618.html,MRTX,0.020848,Neutral,0.0
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,MRTX,0.098659,Neutral,0.0
70 Biggest Movers From Friday,20220531T091540,https://www.benzinga.com/news/22/05/27467950/70-biggest-movers-from-friday,MRTX,0.084702,Neutral,0.073609
Mid-Afternoon Market Update: Dow Rises 100 Points; Kiromic BioPharma Shares Spike Higher,20220607T185012,https://www.benzinga.com/news/earnings/22/06/27596593/mid-afternoon-market-update-dow-rises-100-points-kiromic-biopharma-shares-spike-higher,MRTX,0.125297,Neutral,0.042565
Mid-Day Market Update: Nasdaq Turns Higher; REV Group Shares Plunge,20220607T160918,https://www.benzinga.com/news/earnings/22/06/27592795/mid-day-market-update-nasdaq-turns-higher-rev-group-shares-plunge,MRTX,0.124196,Neutral,0.056604
38 Stocks Moving In Tuesday's Mid-Day Session,20220607T160117,https://www.benzinga.com/news/22/06/27592553/38-stocks-moving-in-tuesdays-mid-day-session,MRTX,0.126617,Neutral,0.007837
"Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday - Akamai Techs  ( NASDAQ:AKAM ) , Arcturus Therapeutics  ( NASDAQ:ARCT ) ",20230809T180316,https://www.benzinga.com/news/23/08/33674368/akamai-technologies-array-technologies-music-hni-penn-entertainment-and-other-big-stocks-moving-high,MRTX,0.10607,Somewhat-Bullish,0.181272
"Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday - Cano Health  ( NYSE:CANO ) , The Chefs' Warehouse  ( NASDAQ:CHEF ) ",20221208T160409,https://www.benzinga.com/news/22/12/30009897/chefs-warehouse-chart-industries-and-some-other-big-stocks-moving-lower-on-thursday,MRTX,0.290607,Bearish,-0.402467
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,MRTX,0.024347,Neutral,-0.03954
